Fact CheckerSign in

NCT05560724Recruiting

Network Properties As Biomarkers for Non-Invasive Brain Stimulation (NIBS) After Stroke

Evaluation of Cortico-Cerebellar Network Properties As Biomarkers for the Responsiveness to Cortico-Cerebellar Brain Stimulation in Stroke Patients

Source: ClinicalTrials.gov · Last updated 17 Dec 2024 · Not updated for over 12 months - ask the site whether it is still open

Brief summary (registry, in English)

The present study will evaluate the potential of cortico-cerebellar network properties derived from neuroimaging in a group of chronic stroke patients to explain inter-subject variability in responsiveness to transcranial direct current stimulation (tDCS) targeting the cortico-spinal and cortico-cerebellar network.

Status (registry)
Recruiting
Study type
Interventional
Enrollment
81 (estimated)
First submitted
21 Sept 2022
Start date
1 Jul 2022
Primary completion date
31 Dec 2025
Lead sponsor
Universitätsklinikum Hamburg-Eppendorf
Diseases
Stroke
NCT number
NCT05560724

What you commit to

  • Study type: Interventional
  • Planned participants: 81
  • From 1 Jul 2022 to the primary completion date, 31 Dec 2025
  • 1 site in 1 country
  • Visits and tests: ask the trial team, the registry does not list them

Built from the registry fields of ClinicalTrials.gov. It describes the study, not your situation.

Who cannot take part

Copied verbatim from ClinicalTrials.gov and grouped by topic. Only the trial team decides who can take part.

Prior treatment

  • known epilepsy, previous epileptic seizure
  • electric implants such as brain stimulator
  • medical history suggesting more than one previous stroke
  • any active drug and alcohol abuse

Other illness

  • severe polyneuropathy and peripheral ischemic vascular diseases; only if they critically influence sensorimotor function of the upper limb
  • any active and severe psychiatric disease (such as psychosis)
  • uncontrolled other medical problems (cardiovascular diseases, instable arrhythmia, arthritis)

Other

  • contraindication against MRI \& tDCS
  • severe cognitive deficits (mini mental state examination, MMSE ≤ 23)

Who the study is looking for

  • patients after first-ever clinical ischemic stroke in the early (\>3 month) or later chronic (\>6 months) stage of recovery
  • persistent motor deficit of the upper extremity
  • stroke location: supratentorial
  • age \> 18 years
  • written informed consent obtained

Age in the registry: 18 years to - · Sex: All · Does not accept healthy volunteers

Full criteria on ClinicalTrials.gov

Sites (1)

Sites in registry order. Pick your city on the disease page to sort them by distance.

SiteCityCountrySite status
University Medical Center Hamburg-Eppendorf, Dept. of Neurology
Coordinator of this site? Confirm its status
HamburgGermanyRecruiting

This page is information, not medical advice. Discuss any trial with your doctor.